SABR is Stereotactive Ablative Radiotherapy also called Stereotactic Body Radiotherapy (SBRT), which is a method of accurately targeting radiotherapy to a tumour from many different directions.
The Consortium was created in 2007 to address the lack of SABR in the UK . SABR is a network of over 300 radiotherapy professionals, forming a multi-disciplinary group involving clinicians, medical physicists and radiographers. The consortium has written national guidelines for lung SABR.
Research is a key focus for the group with many trials in development.
As well as holding regular meetings where cancer specialists from across Europe share their knowledge, the SABR Consortium runs its own forum where radiotherapy professionals regularly contribute to share ideas and information.
The current NHS Clinical Commissioning Policy can be found here